Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Glenmark Pharma finds...

    Glenmark Pharma finds way into Dow Jones Sustainability Indices

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-09-19T16:02:52+05:30  |  Updated On 19 Sept 2018 4:02 PM IST
    Glenmark Pharma finds way into Dow Jones Sustainability Indices

    Glenmark Pharmaceuticals inducted into the Dow Jones Sustainability Indices (DJSI) Emerging Market 2018, one of the most prestigious global sustainability benchmarks.


    New Delhi: Glenmark Pharmaceuticals Ltd. has been listed on the Dow Jones Sustainability Indices 2018. Dow Jones Sustainability Index (DJSI) is one of the most esteemed global benchmarks for sustainable business practices.


    Only the top-ranked companies in terms of Corporate Sustainability within each industry are selected to be featured in the index. The inclusion in this list is considered highly prestigious by global investors, financial analysts and other stakeholders and also serves as a benchmark for investors who integrate sustainability considerations into their portfolios.


    Speaking on the achievement, Glenn Saldanha, Chairman and Managing Director said, “Glenmark is proud to be included in the Dow Jones Sustainability Emerging Market Index 2018. Being listed in the index is a landmark achievement for us and it re-emphasizes our efforts towards Environment, Social and Governance factors and how over the years we have emerged as a leader in the area of sustainability. This honour has motivated us to continue working on strengthening our actions to build a sustainable future.”


    The DJSI Emerging Market leaders were chosen from over 800 companies who were assessed, out of which 94 made it to the Index. A focused approach to sustainable practices in conducting the core business, operations and social investments have facilitated Glenmark to be among the only 2 pharmaceutical companies to be featured in the Emerging Market Index. From India, there are only 10 companies who have made it to this prestigious listing.


    The evaluation included 24 long-term economic, environmental and social criteria. Glenmark secured high scores for Marketing Practices, Product Quality and Recall, Environmental Policy and Management System, Corporate Citizenship and Philanthropy, Health Outcome Contribution and Code of Business Conduct.

    Dow JonesDow Jones Sustainability IndicesEmerging Market IndexGlenmarkGlenmark PharmaGlenmark PharmaceuticalsGlenn SaldanhaMarketing PracticesPhilanthropyProduct Quality and Recall

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok